[PDF][PDF] Small molecular NIR-II fluorophores for cancer phototheranostics

H Dai, Q Shen, J Shao, W Wang, F Gao, X Dong - The Innovation, 2021 - cell.com
Phototheranostics integrates deep-tissue imaging with phototherapy (containing
photothermal therapy and photodynamic therapy), holding great promise in early diagnosis …

Positron emission tomography in multiple sclerosis—straight to the target

B Bodini, M Tonietto, L Airas, B Stankoff - Nature reviews Neurology, 2021 - nature.com
Following the impressive progress in the treatment of relapsing–remitting multiple sclerosis
(MS), the major challenge ahead is the development of treatments to prevent or delay the …

Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis

M Sucksdorff, M Matilainen, J Tuisku, E Polvinen… - Brain, 2020 - academic.oup.com
Overactivation of microglia is associated with most neurodegenerative diseases. In this
study we examined whether PET-measurable innate immune cell activation predicts multiple …

Smouldering multiple sclerosis: the 'real MS'

G Giovannoni, V Popescu, J Wuerfel… - Therapeutic …, 2022 - journals.sagepub.com
Using a philosophical approach or deductive reasoning, we challenge the dominant clinico-
radiological worldview that defines multiple sclerosis (MS) as a focal inflammatory disease …

Microglia in multiple sclerosis–pathogenesis and imaging

L Airas, VW Yong - Current Opinion in Neurology, 2022 - journals.lww.com
Microglia in multiple sclerosis – pathogenesis and imaging : Current Opinion in Neurology
Microglia in multiple sclerosis – pathogenesis and imaging : Current Opinion in Neurology Log …

Extensive brain pathologic alterations detected with 7.0-T MR spectroscopic imaging associated with disability in multiple sclerosis

E Heckova, A Dal-Bianco, B Strasser, GJ Hangel… - Radiology, 2022 - pubs.rsna.org
Background MR spectroscopic imaging (MRSI) allows in vivo assessment of brain
metabolism and is of special interest in multiple sclerosis (MS), where morphologic MRI …

Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET

M Nylund, M Sucksdorff, M Matilainen… - Brain …, 2022 - academic.oup.com
Chronic active lesions are promotors of neurodegeneration and disease progression in
multiple sclerosis. They harbour a dense rim of activated innate immune cells at the lesion …

High serum neurofilament associates with diffuse white matter damage in MS

M Saraste, S Bezukladova, M Matilainen… - Neurology …, 2020 - AAN Enterprises
Objective To evaluate to which extent serum neurofilament light chain (NfL) increase is
related to diffusion tensor imaging–MRI measurable diffuse normal-appearing white matter …

[HTML][HTML] Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI

M Saraste, S Bezukladova, M Matilainen… - Multiple Sclerosis and …, 2021 - Elsevier
Background Astrocytes and microglial cells are now recognized as active players in
contributing to the diffuse neuroaxonal damage associated with disease progression of …

TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis

E Polvinen, M Matilainen, M Nylund… - Neurology …, 2023 - AAN Enterprises
Background and Objectives In the multiple sclerosis (MS) brain, chronic active lesions can
be detected using MRI-and PET-based methods. In this study, we investigated whether the …